![Chip Baird](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chip Baird
Plus aucun poste en cours
Profil
William Denise Baird is currently President & Chief Executive Officer at Poplar Therapeutics, Inc. since 2025 and Non-Executive Director at Deep Genomics, Inc. since 2026.
Former roles include President, Chief Executive Officer & Director at 2seventy Bio, Inc. from 2024 to 2025; Independent Director at Axcella Health, Inc. from 2018 to 2023; Director at Amicus Therapeutics UK Ltd.; Chief Financial Officer at Amicus Therapeutics, Inc. from 2012 to 2018; Chief Financial Officer at PTC Therapeutics, Inc. from 2005 to 2012; Chief Financial & Accounting Officer at Genetix Biotherapeutics, Inc. in 2021; and Engagement Manager at The Lek from 1999 to 2002.
Education includes an MBA from The Wharton School of the University of Pennsylvania and undergraduate studies at Edmund A. Walsh School of Foreign Service.
Postes actifs de Chip Baird
| Sociétés | Poste | Début |
|---|---|---|
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Directeur/Membre du Conseil | 23/07/2026 |
Anciens postes connus de Chip Baird
| Sociétés | Poste | Fin |
|---|---|---|
| 2SEVENTY BIO, INC. | Directeur Général | 13/05/2025 |
| AXCA HEALPAR | Directeur/Membre du Conseil | 01/11/2023 |
| GENETIX BIOTHERAPEUTICS, INC. | Directeur Financier/CFO | 04/11/2021 |
| AMICUS THERAPEUTICS, INC. | Directeur Financier/CFO | 19/12/2018 |
| PTC THERAPEUTICS, INC. | Directeur Financier/CFO | 01/04/2012 |
Formation de Chip Baird
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edmund A. Walsh School of Foreign Service
 Edmund A. Walsh School of Foreign Service Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Health Technology |
Amicus Therapeutics UK Ltd.
 Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
